Disappointing recent cholesterol-lowering drug trials: is it not time for a full reappraisal of the cholesterol theory?

World Rev Nutr Diet. 2009;100:80-89. doi: 10.1159/000235714. Epub 2009 Aug 17.
No abstract available

Publication types

  • Review

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Azetidines / therapeutic use
  • Cholesterol / blood*
  • Coronary Disease / complications
  • Coronary Disease / drug therapy
  • Drug Therapy, Combination
  • Ezetimibe
  • Fluorobenzenes / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hyperlipoproteinemia Type II / complications
  • Hyperlipoproteinemia Type II / drug therapy*
  • Pyrimidines / therapeutic use
  • Randomized Controlled Trials as Topic
  • Rosuvastatin Calcium
  • Simvastatin / therapeutic use
  • Sulfonamides / therapeutic use

Substances

  • Anticholesteremic Agents
  • Azetidines
  • Fluorobenzenes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrimidines
  • Sulfonamides
  • Rosuvastatin Calcium
  • Cholesterol
  • Simvastatin
  • Ezetimibe